Meditech Spine LLC recently announced it has received FDA clearance for its Talos interbody devices to be used with allograft comprised of cancellous or corticocancellous bone graft.
According to a company press release, all of Meditech’s interbody cervical devices and lumbar devices are now indicated for use with autograft or allograft.
Meditech is the only company with FDA clearance of Invibio’s PEEK-OPTIMA HA Enhanced utilizing autograft or allograft with the Talos-C (HA) cervical interbody devices, according to a press release.
“This continues to build on our platform of products, especially our recently cleared Talos-C (HA) devices that are being adopted by surgeons,” Meditech Spine’s Vice President of Sales Bob Wolownik, said in a press release. “By combining HA with the world’s leading spinal implant material PEEK-OPTIMA Natural and giving surgeons the option of autograft or allograft, we have delivered a game-changing implant.”